JLE

Médecine de la Reproduction

MENU

Transgender and Fertility preservation: Data of the French Cecos network Volume 24, issue 1, Janvier-Février-Mars 2022

Figures


  • Figure 1.

Tables

Authors
1 Cecos, hôpitaux universitaires Paris Seine-Saint-Denis, site Jean Verdier, Bondy, France
2 Cecos Nord Lille CHRU de Lille, Hôpital Calmette, Lille, France
3 Cecos Hôpitaux Universitaires Paris Tenon, Paris, France
4 Cecos Champagne-Ardenne, CHU de Reims Hôpital d’Enfants, Reims, France
5 Cecos Pays de la Loire Nantes Service de Biologie de la reproduction, Nantes, France
6 Cecos Aquitaine Bordeaux Maternité CHU Pellegrin 33076 Bordeaux France
7 Cecos Alsace Strasbourg CMCO, Schiltighem, France
8 Cecos Rhône Alpes Grenoble, CHU Couple Enfant, Grenoble, France
9 Cecos Lorraine Nancy Maternité régionale Universitaire 54042 NANCY France
10 Biologie de la reproduction Cecos, Hôpital de La Cavale Blanche 29200 BREST France
11 Service de médecine et biologie de la reproduction, Cecos CHRU Bretonneau, Tours, France
12 Cecos Paris Beclere Hôpital Antoine Béclère, Clamart, France
13 Cecos Basse Normandie Caen CHU de Caen, Caen, France
14 Cecos Océan Indien La Réunion, Centre d’AMP CHU de La Réunion, Saint Pierre, France
15 Cecos ALSACE Mulhouse groupe hospitalier de la région de Mulhouse et Sud Alsace, Mulhouse, France
16 Cecos Pays de Loire, Antenne Angers, laboratoire de biologie de la reproduction, Angers, France
17 Service de biologie et médecine de la reproduction-cryobiologie, Cecos CHRU Jean Minjoz, Besançon, France
18 Cecos Auvergne Clermont Ferrand, CHU Estaing, Clermont Ferrand, France
19 Cecos Picardie Amiens, Amiens, France
20 Cecos Franche Comté Bourgogne, Dijon, France
21 Cecos Provence Alpes Côte d’Azur Nice, Centre de reproduction CHU de Nice, Nice, France
22 Cecos Provence Alpes Côte d’Azur Marseille, CHU La conception, Marseille, France
23 Normandie Univ, UniRouen, EA 4308 “Gametogenesis and Gamete Quality”, Rouen University Hospital, Biology of Reproduction-Cecos Laboratory, Rouen, France

In France, fertility preservation (FP) was until recently very rarely offered to transgender persons despite the existing desire for a child. The proposed treatments, hormone therapy and reassignment surgery, are far from being without risk on gametic quality and production. French law authorizes

fertility preservation before any treatment with sterilizing risks. Thus, several Cecos centers have responded to these new requests. A national multicenter survey was conducted between January 2019 and October 2020 in 28 centers of the French Cecos network. Each center was surveyed to find out how many

TG individuals were coming, being informed, and being managed for FP. During this period, nearly 600 trans individuals presented to a Cecos center. Trans men were significantly younger than trans women. Nearly half of the trans people who came were able to perform oocyte or sperm conservation. However, 66% of trans women did so while only 11% of trans men did. Thus, the vast majority of Cecos centers are able to treat trans people for FP. This is the first study with such a large population.